Monument Therapeutics secures £1.1m for precision neuroscience treatments
Digital biomarkers are being utilized by Monument Therapeutics to develop targeted treatments for high-unmet-need areas in psychiatry and neurology. The Macclesfield-based clinical-stage biotechnology...